Overview

Regulation of Bone Formation in Renal Osteodystrophy

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
To examine the effects of two types of active vitamin D (calcitriol and doxercalciferol) and two phosphate binders (sevelamer and calcium carbonate) on the bone disease and blood tests of children with kidney failure
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
1 alpha-hydroxyergocalciferol
Calcitriol
Calcium
Calcium Carbonate
Calcium, Dietary
Cholecalciferol
Dihydroxycholecalciferols
Ergocalciferols
Sevelamer
Vitamin D
Vitamins